Lucas Ward
Stock Analyst at Ascendiant
(0.03)
# 4,689
Out of 4,690 analysts
57
Total ratings
13.3%
Success rate
-55.5%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Reiterated: Buy | $3 → $3.1 | $0.2249 | +1,278.39% | 12 | Jun 4, 2026 | |
| ACON Aclarion | Maintained: Buy | $7 → $7.5 | $2.40 | +212.50% | 8 | May 28, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Maintained: Buy | $4.2 → $3.7 | $1.03 | +259.22% | 10 | May 22, 2026 | |
| LIQT LiqTech International | Maintained: Buy | $4.3 → $4.4 | $0.5701 | +671.79% | 10 | May 20, 2026 | |
| HSCS HeartSciences | Maintained: Buy | $9.2 → $8 | $3.03 | +164.03% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Maintained: Buy | $30 → $10 | $7.65 | n/a | 5 | Apr 30, 2025 |
Vivos Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $3 → $3.1
Current: $0.2249
Upside: +1,278.39%
Aclarion
May 28, 2026
Maintained: Buy
Price Target: $7 → $7.5
Current: $2.40
Upside: +212.50%
60 Degrees Pharmaceuticals
May 22, 2026
Maintained: Buy
Price Target: $4.2 → $3.7
Current: $1.03
Upside: +259.22%
LiqTech International
May 20, 2026
Maintained: Buy
Price Target: $4.3 → $4.4
Current: $0.5701
Upside: +671.79%
HeartSciences
Mar 23, 2026
Maintained: Buy
Price Target: $9.2 → $8
Current: $3.03
Upside: +164.03%
Vision Marine Technologies
Apr 30, 2025
Maintained: Buy
Price Target: $30 → $10
Current: $7.65
Upside: n/a